Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cognis Nutrition and Health

This article was originally published in The Tan Sheet

Executive Summary

Henkel Nutrition and Health Group, a division of Henkel Corp., is renamed Cognis Nutrition and Health as of Jan. 1, 2000. The company adopted the new name and logo under new VP Michael Sundos, PhD, with the hopes of reworking its image as a customer-oriented manufacturer; Cognis comes from the Latin root "cognoscere," meaning to realize or notice. The division is now concentrating on marketing products with lutein, including its Xangold brand and Whitehall Robins' Centrum and Centrum Silver, for which Cognis supplies lutein esters. The division also plans to release Prevastein, a product containing soy isoflavones, soon in collaboration with Central Soya

You may also be interested in...



Cognis

Most or all of the nutritionals, ingredients and chemicals company could be on the selling block, parent company Henkel Group announces Nov. 13. Dusseldorf, Germany-based Henkel split its chemical products business off to form Cognis earlier this year intending to seek a minority partner, but now says it has been unable to secure an advantageous deal (1"The Tan Sheet" Feb. 14, In Brief). Henkel wants to divert resources from Cognis - which accounts for 23% of the firm's worldwide business - to focus on consumer products. The firm stresses any moves made involving Cognis are unrelated to its desire to acquire the Clairol hair care franchise from Bristol-Myers Squibb (2"The Tan Sheet" Oct. 2, p. 5)

Cognis

Most or all of the nutritionals, ingredients and chemicals company could be on the selling block, parent company Henkel Group announces Nov. 13. Dusseldorf, Germany-based Henkel split its chemical products business off to form Cognis earlier this year intending to seek a minority partner, but now says it has been unable to secure an advantageous deal (1"The Tan Sheet" Feb. 14, In Brief). Henkel wants to divert resources from Cognis - which accounts for 23% of the firm's worldwide business - to focus on consumer products. The firm stresses any moves made involving Cognis are unrelated to its desire to acquire the Clairol hair care franchise from Bristol-Myers Squibb (2"The Tan Sheet" Oct. 2, p. 5)

Cognis

Most or all of the nutritionals, ingredients and chemicals company could be on the selling block, parent company Henkel Group announces Nov. 13. Dusseldorf, Germany-based Henkel split its chemical products business off to form Cognis earlier this year intending to seek a minority partner, but now says it has been unable to secure an advantageous deal (1"The Tan Sheet" Feb. 14, In Brief). Henkel wants to divert resources from Cognis - which accounts for 23% of the firm's worldwide business - to focus on consumer products. The firm stresses any moves made involving Cognis are unrelated to its desire to acquire the Clairol hair care franchise from Bristol-Myers Squibb (2"The Tan Sheet" Oct. 2, p. 5)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090853

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel